相关实验视频
Updated: Jul 26, 2026
08:28
Development of an In Vitro Ocular Platform to Test Contact Lenses
Published on: April 6, 2016
10.7K
对潜在的吸毒隐形眼镜技术的审查
Tina Lovrec-Krstič1, Kristjan Orthaber2, Uroš Maver3
1Community Health Centre Dr. Adolfa Drolca Maribor, Department of Radiology with Centre for Breast Disease, Ulica talcev 5, 2000 Maribor, Slovenia.
Materials (Basel, Switzerland)
|May 27, 2023
概括
含有药物的隐形眼镜为无滴眼疗法提供了一个有前途的解决方案,解决了眼科中改善药物输送的未满足需求. 这一创新可以彻底改变患者的遵守和治疗日益增加的眼病.
科学领域:
- 眼科医生 眼科 眼科
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
背景情况:
- 眼科在诊断,治疗和疾病发病率方面面临着指数级增长.
- 人口老龄化和气候变化正在增加眼科患者数量,给医疗保健系统带来压力,并冒着治疗不足的风险.
- 目前的眼滴疗法在符合性,稳定性和寿命方面存在局限性,这凸显了对先进的眼部药物输送的未满足需求.
研究的目的:
- 审查药物载体隐形眼镜在眼部药物输送中的当前作用和未来潜力.
- 探索与眼滴相比,提供更好的患者服药性,稳定性和寿命的替代药物输送方法.
- 为了确定有前途的材料和制备技术,用于药物泄露的隐形眼镜.
主要方法:
- 对基于隐形眼镜的眼部药物输送现有文献的审查.
- 分析各种用于制造含有药物的隐形眼镜的材料.
- 检查这些镜片的药物结合和制备方法.
主要成果:
- 含有药物的隐形眼镜被认为是无滴眼疗法的非常有前途的方法.
- 与传统眼滴相比,这些镜头在药物输送遵守,稳定性和持续释放方面提供了潜在的改进.
- 目前正在进行的研究探索各种材料和制备技术以优化性能.
结论:
- 含有药物的隐形眼镜代表了无滴眼疗法的重大进步.
- 这项技术有可能通过克服当前药物输送方法的局限性来改变临床眼科实践.
- 对材料和制剂的进一步开发是实现其全部临床潜力的关键.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...